4//SEC Filing
Tenenbaum Fabian 4
Accession 0001600132-18-000023
CIK 0001600132other
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 4:55 PM ET
Size
6.7 KB
Accession
0001600132-18-000023
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-12+550,000→ 550,000 totalExercise: $2.03Exp: 2028-01-12→ Common Stock (550,000 underlying) - Award
Common Stock
2018-01-12+55,419→ 318,469 total
Footnotes (1)
- [F1]This option was granted on January 12, 2018. This option vests in quarterly installments over a four-year period from the date of grant.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001641300
Filing Metadata
- Form type
- 4
- Filed
- Jan 16, 7:00 PM ET
- Accepted
- Jan 17, 4:55 PM ET
- Size
- 6.7 KB